TIBSOVO (ivosidenib tablets)

TIBSOVO is a prescription medicine used to treat: • acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) mutation • adults with bile duct cancer (cholangiocarcinoma)

Home |  (ivosidenib tablets)

TIBSOVO (ivosidenib tablets) Price In India and Overseas
TIBSOVO (ivosidenib tablets)

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

TIBSOVO (ivosidenib tablets)

Ivosidenib is approved to treat adults whose cancer has a certain mutation in the IDH1 gene, including: Acute myeloid leukemia, Cholangiocarcinoma (bile duct cancer). Ivosidenib is also being studied in the treatment of other types of cancer.

Tibsovo, A drug used alone or with other drugs to treat adults with certain types of acute myeloid leukemia or cholangiocarcinoma (a type of bile duct cancer) that have a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Tibsovo blocks the protein made by the mutated IDH1 gene, which may help keep cancer cells from growing. It is a type of enzyme inhibitor and a type of targeted therapy. Also called ivosidenib.

Ivosidenib, A drug used alone or with other drugs to treat adults with certain types of acute myeloid leukemia or cholangiocarcinoma (a type of bile duct cancer) that have a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Ivosidenib blocks the protein made by the mutated IDH1 gene, which may help keep cancer cells from growing. It is a type of enzyme inhibitor and a type of targeted therapy. Also called Tibsovo.

Drug (Brand / Generic): TIBSOVO / ivosidenib
Current Indications: acute myeloid leukemia or cholangiocarcinoma
Marketed by:: Servier Pharmaceuticals
Approval Date: 2018

Available as (Form & Strength): Tablets: 250 mg

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.